title: Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study.
authors.affiliation: Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Barts Health NHS Trust, London, UK; NHS Blood and Transplant, London, UK.
authors.forename: Laura
authors.initials: L
authors.lastname: Green
authors.forename: Raza
authors.initials: R
authors.lastname: Alikhan
authors.forename: Nicola
authors.initials: N
authors.lastname: Curry
authors.forename: Rhona
authors.initials: R
authors.lastname: Maclean
authors.forename: Khalid
authors.initials: K
authors.lastname: Saja
authors.forename: Simon
authors.initials: S
authors.lastname: Stanworth
authors.forename: Campbell
authors.initials: C
authors.lastname: Tait
authors.forename: Joachim
authors.initials: J
authors.lastname: Tan
authors.forename: Joan
authors.initials: J
authors.lastname: Morris
authors.forename: Peter
authors.initials: P
authors.lastname: MacCallum
mesh_terms: D000284:Administration, Oral; D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration*; D000925:Anticoagulants / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D064887:Observational Studies as Topic; D006113:United Kingdom; D014859:Warfarin / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D014859:Warfarin
keywords: anticoagulants; bleeding disorders; warfarin